ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,777Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 87

$1.05M Total Retail Price of All Prescriptions

Rank: 1 out of 87

1,034 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 13,701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
CARVEDILOL 1,229 1,123 1 4
CLOPIDOGREL 677 560 2 6
METOPROLOL SUCCINATE 670 560 3 1
LISINOPRIL 590 471 4 3
SIMVASTATIN 586 526 5 5
AMLODIPINE BESYLATE 503 438 6 9
PRAVASTATIN SODIUM 493 425 7 18
ATORVASTATIN CALCIUM 465 391 8 11
PLAVIX 462 407 9 12
METOPROLOL TARTRATE 397 348 10 2
CRESTOR 372 332 11 14
LOSARTAN POTASSIUM 323 270 12 16
FUROSEMIDE 320 290 13 8
METFORMIN HCL 318 219 14 36
DIGOXIN 310 288 15 13
WARFARIN SODIUM 293 269 16 7
TORSEMIDE 282 240 17 62
BYSTOLIC 279 259 18 31
BENAZEPRIL HCL 258 234 19 75
XARELTO 251 248 20 53
SPIRONOLACTONE 210 190 21 22
AMLODIPINE BESYLATE-BENAZEPRIL 208 175 22 76
LEVOTHYROXINE SODIUM 206 198 23 24
ZETIA 201 178 24 27
ISOSORBIDE MONONITRATE ER 181 151 25 10
RAMIPRIL 180 164 26 28
OMEPRAZOLE 179 151 27 26
CHLORTHALIDONE 177 131 28 94
FENOFIBRATE 163 137 29 47
LOVAZA 151 132 30 57
ATENOLOL 149 127 31 15
LOSARTAN-HYDROCHLOROTHIAZIDE 144 143 32 54
NITROGLYCERIN PATCH 138 129 33 30
PRADAXA 132 127 34 20
TRANDOLAPRIL 124 117 35 92
NITROSTAT 119 96 36 19
DIOVAN 113 107 37 37
ENALAPRIL MALEATE 108 84 38 29
KLOR-CON M20 97 86 39 38
RANEXA 93 79 40 23
POTASSIUM CHLORIDE 92 84 41 17
QUINAPRIL HCL 88 78 42 81
NEXIUM 86 75 43 50
IRBESARTAN 80 75 44 122
VYTORIN 74 63 45 58
ALLOPURINOL 73 73 46 63
TAMSULOSIN HCL 70 62 47 64
PROPAFENONE HCL 69 63 48 33
LIPITOR 69 51 48 59
AZOR 67 66 50 106
JANUVIA 66 53 51 79
MULTAQ 65 65 52 41
VERAPAMIL ER 64 49 53 55
TRICOR 63 54 54 51
SOTALOL 60 60 55 32
PROPRANOLOL HCL 57 57 56 135
FELODIPINE ER 55 55 57 139
EFFIENT 54 38 58 39
PANTOPRAZOLE SODIUM 52 43 59 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.